By injecting the heart with synthetic mRNA that encodes for relaxin, the mRNA shot directs human cells to generate the hormone. Increased blood movement allows for new blood vessels to grow and helps restore blood flow along arteries and veins. This week, the drug maker announced that the first patients were given the injection in a phase one clinical trial. Moderna CEO Stéphane Bancel said, 'We have now in the clinic a super exciting program where we inject mRNA into people's hearts after a heart attack to grow back new blood vessels to help revascularize the heart. Moderna CEO Stéphane Bancel told Sky News: 'It's like science fiction medicine'.
Moderna's mRNA COVID 'vaccine' has been shown to cause major heart problems. A Swiss study found the COVID mRNA shots injured the hearts of ALL its recipients, with 2.8% having levels associated with subclinical myocarditis. NewsWars reported that Moderna has used its profits from its mRNA COVID shot to fund their new product that treats those same heart problems. "Absolutely diabolical."

The shot encodes for relaxin, a hormone which is known to improve blood flow
Patients have received the injection in a phase one trial looking at dosage levels
Moderna CEO Stéphane Bancel told Sky News: 'It's like science fiction medicine'
Moderna is developing an mRNA shot that is injected directly into the hearts of heart attack and heart failure patients.

The 'vaccine' uses the same technology as the company's flagship Covid jab and is designed for people weeks or months after a heart attack to help them recover.

It works by instructing human heart cells to generate a hormone that is known to improve blood flow, helping restore damaged heart muscles.